Exploiting ROS and metabolic differences to selectively killing cisplatin resistant lung cancer

被引：0
作者：
Wangpaichitr, Medhi
Wu, Chunjing
Li, Ying Ying
Shah, Sumedh
Chen, Shu-Mei
Dinh, Vy
Kuo, Macus T.
Feun, Lynn G.
Savaraj, Niramol
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1038
引用
收藏
页数：3
相关论文
共 50 条
[41]   Fentanyl induces autophagy via activation of the ROS/MAPK pathway and reduces the sensitivity of cisplatin in lung cancer cells [J].
Yao, Jiaqi ;
Ma, Chi ;
Gao, Wei ;
Liang, Jinxiao ;
Liu, Chang ;
Yang, Hongfang ;
Yan, Qiu ;
Wen, Qingping .
ONCOLOGY REPORTS, 2016, 36 (06) :3363-3370
[42]   The Relationship of Thioredoxin-1 and Cisplatin Resistance: Its Impact on ROS and Oxidative Metabolism in Lung Cancer Cells [J].
Wangpaichitr, Medhi ;
Sullivan, Elizabeth J. ;
Theodoropoulos, George ;
Wu, Chunjing ;
You, Min ;
Feun, Lynn G. ;
Lampidis, Theodore J. ;
Kuo, Macus T. ;
Savaraj, Niramol .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (03) :604-615
[43]   Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer [J].
Salaroglio, Iris C. ;
Belisario, Dimas Carolina ;
Akman, Muhlis ;
La Vecchia, Sofia ;
Godel, Martina ;
Anobile, Dario Pasquale ;
Ortone, Giacomo ;
Digiovanni, Sabrina ;
Fontana, Simona ;
Costamagna, Costanzo ;
Rubinstein, Menachem ;
Kopecka, Joanna ;
Riganti, Chiara .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
[44]   Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer [J].
Iris C. Salaroglio ;
Dimas Carolina Belisario ;
Muhlis Akman ;
Sofia La Vecchia ;
Martina Godel ;
Dario Pasquale Anobile ;
Giacomo Ortone ;
Sabrina Digiovanni ;
Simona Fontana ;
Costanzo Costamagna ;
Menachem Rubinstein ;
Joanna Kopecka ;
Chiara Riganti .
Journal of Experimental & Clinical Cancer Research, 41
[45]   CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE IN ETOPOSIDE-RESISTANT AND CISPLATIN-RESISTANT SMALL-CELL LUNG-CANCER [J].
SHEPHERD, FA ;
EVANS, WK ;
MACCORMICK, R ;
FELD, R ;
YAU, JC .
CANCER TREATMENT REPORTS, 1987, 71 (10) :941-944
[46]   Inhibition of MAT2A-Related Methionine Metabolism Enhances The Efficacy of Cisplatin on Cisplatin-Resistant Cells in Lung Cancer [J].
Zhao, Xiaoya ;
Wang, Lude ;
Lin, Haiping ;
Wang, Jing ;
Fu, Jianfei ;
Zhu, Dan ;
Xu, Wenxia .
CELL JOURNAL, 2022, 24 (04) :204-211
[47]   Kynurenine - Aryl hydrocarbon receptor axis: A crucial modulator of immunometabolism in cisplatin resistant lung cancer [J].
Wangpaichitr, Medhi ;
Nguyen, Dan J. M. ;
Li, Ying-Ying ;
Wu, Chunjing ;
Feun, Lynn G. ;
Savaraj, Niramol .
CANCER RESEARCH, 2019, 79 (13)
[48]   The effects of combined treatment of erlotinib and cisplatin in resistant lung cancer and the role of autophagy in response to chemotherapy [J].
Lee, Jasmine G. ;
Wu, Reen .
CANCER RESEARCH, 2011, 71
[49]   Cisplatin-Resistant CD44+ Lung Cancer Cells Are Sensitive to Auger Electrons [J].
Madsen, Karina Lindbog ;
Gerke, Oke ;
Hoilund-Carlsen, Poul F. ;
Olsen, Birgitte Brinkmann .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
[50]   Circulating tumor cells from a 4-dimensional lung cancer model are resistant to cisplatin [J].
Vishnoi, Monika ;
Mishra, Dhruva K. ;
Thrall, Michael J. ;
Kurie, Jonathan M. ;
Kim, Min P. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (03) :1056-1063
12345